Swiss National Bank’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-126,300
| Closed | -$546K | – | 2609 |
|
|
2023
Q3 | $546K | Buy |
126,300
+4,100
| +3% | +$22.8K | ﹤0.01% | 2491 |
|
|
2023
Q2 | $805K | Hold |
122,200
| – | – | ﹤0.01% | 2404 |
|
|
2023
Q1 | $830K | Sell |
122,200
-14,400
| -11% | -$101K | ﹤0.01% | 2352 |
|
|
2022
Q4 | $1.01M | Buy |
136,600
+2,600
| +2% | +$25.3K | ﹤0.01% | 2338 |
|
|
2022
Q3 | $1.32M | Buy |
134,000
+2,300
| +2% | +$24.3K | ﹤0.01% | 2160 |
|
|
2022
Q2 | $1.44M | Hold |
131,700
| – | – | ﹤0.01% | 2144 |
|
|
2022
Q1 | $1.49M | Buy |
131,700
+8,900
| +7% | +$117K | ﹤0.01% | 2202 |
|
|
2021
Q4 | $1.93M | Hold |
122,800
| – | – | ﹤0.01% | 2087 |
|
|
2021
Q3 | $2.1M | Buy |
122,800
+1,800
| +1% | +$31.5K | ﹤0.01% | 2023 |
|
|
2021
Q2 | $2.6M | Sell |
121,000
-4,000
| -3% | -$71.6K | ﹤0.01% | 1928 |
|
|
2021
Q1 | $1.88M | Buy |
125,000
+1,400
| +1% | +$22.7K | ﹤0.01% | 2038 |
|
|
2020
Q4 | $1.62M | Hold |
123,600
| – | – | ﹤0.01% | 2027 |
|
|
2020
Q3 | $1.19M | Buy |
123,600
+3,800
| +3% | +$40.6K | ﹤0.01% | 1995 |
|
|
2020
Q2 | $1.37M | Buy |
119,800
+26,700
| +29% | +$302K | ﹤0.01% | 1917 |
|
|
2020
Q1 | $965K | Buy |
93,100
+1,300
| +1% | +$16.1K | ﹤0.01% | 1844 |
|
|
2019
Q4 | $1.51M | Buy |
91,800
+2,300
| +3% | +$34.8K | ﹤0.01% | 1893 |
|
|
2019
Q3 | $1.19M | Buy |
89,500
+1,400
| +2% | +$19.5K | ﹤0.01% | 1968 |
|
|
2019
Q2 | $1.24M | Sell |
88,100
-7,400
| -8% | -$118K | ﹤0.01% | 1995 |
|
|
2019
Q1 | $1.76M | Buy |
95,500
+2,900
| +3% | +$66.1K | ﹤0.01% | 1745 |
|
|
2018
Q4 | $2.42M | Buy |
92,600
+3,600
| +4% | +$84.6K | ﹤0.01% | 1442 |
|
|
2018
Q3 | $2.04M | Hold |
89,000
| – | – | ﹤0.01% | 1708 |
|
|
2018
Q2 | $1.7M | Hold |
89,000
| – | – | ﹤0.01% | 1808 |
|
|
2018
Q1 | $1.5M | Buy |
89,000
+19,500
| +28% | +$326K | ﹤0.01% | 1825 |
|
|
2017
Q4 | $1.06M | Hold |
69,500
| – | – | ﹤0.01% | 2063 |
|
|
2017
Q3 | $1.24M | Hold |
69,500
| – | – | ﹤0.01% | 1920 |
|
|
2017
Q2 | $1.13M | Buy |
69,500
+6,100
| +10% | +$87.9K | ﹤0.01% | 1974 |
|
|
2017
Q1 | $888K | Hold |
63,400
| – | – | ﹤0.01% | 2101 |
|
|
2016
Q4 | $1.01M | Hold |
63,400
| – | – | ﹤0.01% | 2029 |
|
|
2016
Q3 | $1.05M | Hold |
63,400
| – | – | ﹤0.01% | 1927 |
|
|
2016
Q2 | $709K | Sell |
63,400
-3,300
| -5% | -$32K | ﹤0.01% | 2164 |
|
|
2016
Q1 | $538K | Buy |
66,700
+13,100
| +24% | +$108K | ﹤0.01% | 2267 |
|
|
2015
Q4 | $499K | Hold |
53,600
| – | – | ﹤0.01% | 2265 |
|
|
2015
Q3 | $605K | Buy |
53,600
+9,400
| +21% | +$115K | ﹤0.01% | 2079 |
|
|
2015
Q2 | $561K | Buy |
44,200
+2,000
| +5% | +$21.6K | ﹤0.01% | 2175 |
|
|
2015
Q1 | $392K | Hold |
42,200
| – | – | ﹤0.01% | 2295 |
|
|
2014
Q4 | $604K | Buy |
42,200
+4,200
| +11% | +$49.7K | ﹤0.01% | 2060 |
|
|
2014
Q3 | $394K | Hold |
38,000
| – | – | ﹤0.01% | 2223 |
|
|
2014
Q2 | $615K | Buy |
+38,000
| New | +$506K | ﹤0.01% | 2051 |
|
Other funds holding VNDA
Swiss National Bank's VNDA Position: Q4 2023 in Review
Swiss National Bank sold out of Vanda Pharmaceuticals (VNDA) in Q4 2023, closing a stake of 126,300 shares — an estimated $546K sold.
Swiss National Bank first reported a position in VNDA in Q2 2014 and held it in 38 quarters. The position peaked at $2.6M in Q2 2021. 157 funds tracked by Wall St. Rank hold VNDA as of Q4 2023.
- Swiss National Bank reported no remaining Vanda Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- Swiss National Bank sold 126,300 Vanda Pharmaceuticals shares in Q4 2023, an estimated $546K.
- Swiss National Bank first reported a position in Vanda Pharmaceuticals in Q2 2014 and held it in 38 quarters.
- Swiss National Bank's Vanda Pharmaceuticals position peaked at $2.6M in Q2 2021.
- 157 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2023.
Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.